Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing.

Torge Rempe Qin Wang Qi Wu Varalakshmi Ballur Narayana Reddy Zachary Newcomer Augusto Miravalle Yang Mao-Draayer

Neurol Neuroimmunol Neuroinflamm

From the Department of Neurology (T.R., V.B.N.R., Z.N., A.M.), University of Florida, Gainesville; and Department of Neurology (Q. Wang, Q. Wu, Y.M.-D.), University of Michigan, Ann Arbor.

Published: May 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136058	PMC
http://dx.doi.org/10.1212/NXI.0000000000000709	DOI Listing

Publication Analysis

Top Keywords

progressive multifocal

multifocal leukoencephalopathy

leukoencephalopathy granule

granule cell

cell neuronopathy

neuronopathy novel

novel mutation

mutation flanking

flanking vp1

vp1 c-terminus

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!